Efficacy and safety results from CheckMate 140, a phase 2 study of nivolumab for relapsed/refractory follicular lymphoma
Title:
Efficacy and safety results from CheckMate 140, a phase 2 study of nivolumab for relapsed/refractory follicular lymphoma
Author:
Armand, Philippe Janssens, Ann Gritti, Giuseppe Radford, John Timmerman, John Pinto, Antonio Mercadal Vilchez, Santiago Johnson, Peter Cunningham, David Leonard, John P. Rodig, Scott J. MartÃn-Regueira, Patricia Sumbul, Anne Samakoglu, Selda Tang, Hao Ansell, Stephen M.